The late Philip S. Low Lab

under the direction of Madduri Srinivasarao

Next Generation Targeted Therapeutics

Drug Development Pipeline

FDA-approved drugs

Cytalux (PDF)
Locametz (PDF)
Pluvicto (PDF)

Drugs in Human Clinical Trials

More information (PDF)